Bin Zhao

Title: The Innovations of Bin Zhao

Introduction

Bin Zhao is a notable inventor based in San Ramon, CA. He has made significant contributions to the field of biotechnology, particularly in the development of assays for detecting specific enzymes and antibodies. With a total of 2 patents, Zhao's work is pivotal in advancing medical diagnostics and therapies.

Latest Patents

Zhao's latest patents include innovative methods for detecting phenylalanine ammonia-lyase and antibodies to this enzyme. The first patent focuses on detecting the presence of a pegylated enzyme, enzyme-specific antibodies, or polyethylene glycol-specific antibodies in bodily fluids or tissues. This method is particularly relevant for patients undergoing enzyme substitution therapy for conditions such as phenylketonuria (PKU) or cancer. The second patent relates to screening body fluids or tissues for antibodies against lysosomal enzymes, which are crucial in enzyme replacement therapy.

Career Highlights

Bin Zhao is currently employed at BioMarin Pharmaceutical Inc., a company renowned for its focus on innovative biopharmaceuticals. His work at BioMarin has allowed him to contribute to groundbreaking research and development in the field of enzyme therapies.

Collaborations

Zhao collaborates with esteemed colleagues, including Erik Damien Foehr and Carlos Fabricio Santamaria. These partnerships enhance the research and development efforts at BioMarin, fostering an environment of innovation and discovery.

Conclusion

Bin Zhao's contributions to biotechnology through his patents and work at BioMarin Pharmaceutical Inc. highlight his role as a key innovator in the field. His advancements in enzyme detection methods are set to improve diagnostic and therapeutic approaches in medicine.